GRIN (ART-5803 Biosimilar Antibody)重組單克隆抗體是一款專為科研需求開發(fā)的生物試劑，具備高特異性和高親和力的分子特性。該產(chǎn)品采用重組DNA技術(shù)制備，通過哺乳動物細(xì)胞表達(dá)系統(tǒng)進(jìn)行生產(chǎn)，確保了蛋白質(zhì)結(jié)構(gòu)的正確性和批間一致性。其核心優(yōu)勢在于能夠精準(zhǔn)識別并結(jié)合靶標(biāo)分子，為生命科學(xué)研究提供可靠的工具支持。 在應(yīng)用場景方面，GRIN (ART-5803) 可廣泛用于細(xì)胞生物學(xué)、分子生物學(xué)及免疫學(xué)等研究領(lǐng)域。例如，在蛋白質(zhì)相互作用分析中，該抗體可作為捕獲試劑或檢測探針，助力解析生物分子網(wǎng)絡(luò)調(diào)控機(jī)制；在細(xì)胞功能研究中，通過特異性阻斷或激活靶標(biāo)蛋白，可深入探究其在信號通路中的作用。此外，該抗體還適用于多種實驗技術(shù)，滿足不同研究場景的需求。 產(chǎn)品質(zhì)量控制嚴(yán)格遵循科研試劑標(biāo)準(zhǔn)，經(jīng)過多輪純化工藝去除雜質(zhì)，確保低內(nèi)毒素水平和高純度。每批次產(chǎn)品均通過效價測定、特異性驗證及穩(wěn)定性測試，保證實驗結(jié)果的可重復(fù)性和可靠性。其穩(wěn)定的分子結(jié)構(gòu)和優(yōu)化的緩沖體系，支持長期儲存于-20℃環(huán)境，便于實驗室靈活安排實驗計劃。 GRIN (ART-5803 Biosimilar Antibody)重組單克隆抗體的開發(fā)旨在為科研人員提供高質(zhì)量的研究工具，助力推動生命科學(xué)領(lǐng)域的基礎(chǔ)研究與應(yīng)用探索。通過精準(zhǔn)靶向和高效結(jié)合特性，該抗體能夠幫助研究團(tuán)隊更深入地揭示生物過程的分子機(jī)制，為疾病研究、藥物開發(fā)等前沿領(lǐng)域提供有力支持。

#N A

GRIN

ART-5803 research-grade biosimilar

Human

Recombinant Human GRIN protein

Homo sapiens (Human)

Non-conjugated

Monoclonal

It differs from different batches. Please contact us to confirm it.

0.01M PBS，pH7.4

Liquid

Validation Status
Application-specific performance (e.g., in flow cytometry, ELISA, IHC or other assay formats) has not yet been experimentally verified by CUSABIO. Users are advised to determine the optimal working conditions empirically in their own assay systems.
Guaranteed Quality
① Antibody purity?> 95% tested by SDS-PAGE.
② Endotoxin level < 0.1EU/ug tested by LAL method.

Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

3-4 weeks

It is a non-therapeutic biosimilar antibody, owning the same variable region from the corresponding approved therapeutic antibody. In conclusion, it is a research-grade biosimilar antibody and expressed in mammalian cell, which can be directly used as positive controls in drug discovery or used for rapid verification of the biological functions of target protein.